Back to search

Peptide record

TPDB40954

PTP-7S Anticancer standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40954
PTP-7S
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 16-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
EENFLGALFKALSKLL
Physicochemical Analysis
C85H137N19O23
RDCQHIMPTWYV
L
1793.14
7.06
2
2
9
+0
1.18
0.544
134.38
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
0
0.00
2
Residue Composition
number
2
A
0
R
1
N
0
D
0
C
2
E
0
Q
1
G
0
H
0
I
5
L
2
K
0
M
2
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 0 C: 0 E: 2 Q: 0 G: 1 H: 0 I: 0 L: 5 K: 2 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
16
C85H137N19O23
1793.14
7.06
+0
1.18
0.544
Free
L
Linear
Free
Anticancer
PTP-7
Evidence Records 2 records
Evidence 1 Activity

Activity

55 - 60% cell viability at 75 µM
Anticancer

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

65% cell viability at 10 µΜ
Anticancer

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
6-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017